• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体信号传导、内吞分选与癌症中的失调

Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.

作者信息

Arora Puneeta, Ricks Tiffany K, Trejo JoAnn

机构信息

Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.

出版信息

J Cell Sci. 2007 Mar 15;120(Pt 6):921-8. doi: 10.1242/jcs.03409.

DOI:10.1242/jcs.03409
PMID:17344429
Abstract

Protease-activated receptors (PARs) are G-protein-coupled receptors (GPCRs) that are activated by a unique proteolytic mechanism. PARs play crucial roles in hemostasis and thrombosis, as well as in inflammation and vascular development. Coagulant proteases, which are generated at sites of vascular injury, act mainly through PARs to elicit signalling in a variety of cell types. Since PARs are irreversibly activated signalling must be tightly regulated. Desensitization and trafficking of proteolytically activated PARs control the magnitude, duration and spatial aspects of receptor signalling. Recent studies have revealed novel endocytic sorting mechanisms that regulate PAR signalling. PARs have also been implicated in tumor progression. PARs are overexpressed in several types of malignant cancer, transmit signals in response to tumor-generated proteases and promote tumor growth, invasion and metastasis. Recent work also indicates that matrix metalloprotease 1 (MMP-1) signals through PAR1 to promote tumor growth and invasion. In addition to PAR overexpression, tumor cells display aberrant PAR1 trafficking, which causes persistent signalling and cellular invasion. Thus, a novel type of gain-of-function in GPCR signalling in cancer can be acquired through dysregulation of receptor trafficking.

摘要

蛋白酶激活受体(PARs)是通过独特的蛋白水解机制被激活的G蛋白偶联受体(GPCRs)。PARs在止血和血栓形成以及炎症和血管发育中发挥关键作用。在血管损伤部位产生的凝血蛋白酶主要通过PARs在多种细胞类型中引发信号传导。由于PARs被不可逆地激活,因此信号传导必须受到严格调控。蛋白水解激活的PARs的脱敏和转运控制着受体信号传导的强度、持续时间和空间方面。最近的研究揭示了调节PAR信号传导的新型内吞分选机制。PARs也与肿瘤进展有关。PARs在几种类型的恶性癌症中过度表达,响应肿瘤产生的蛋白酶传递信号并促进肿瘤生长、侵袭和转移。最近的研究还表明,基质金属蛋白酶1(MMP-1)通过PAR1发出信号以促进肿瘤生长和侵袭。除了PAR过度表达外,肿瘤细胞还表现出异常的PAR1转运,这会导致持续的信号传导和细胞侵袭。因此,癌症中GPCR信号传导的一种新型功能获得可以通过受体转运失调来实现。

相似文献

1
Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.蛋白酶激活受体信号传导、内吞分选与癌症中的失调
J Cell Sci. 2007 Mar 15;120(Pt 6):921-8. doi: 10.1242/jcs.03409.
2
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.PAR1是一种基质金属蛋白酶-1受体,可促进乳腺癌细胞的侵袭和肿瘤发生。
Cell. 2005 Feb 11;120(3):303-13. doi: 10.1016/j.cell.2004.12.018.
3
Protease signaling in tumor progression.蛋白酶信号传导在肿瘤进展中的作用
Thromb Res. 2007;120 Suppl 2:S75-81. doi: 10.1016/S0049-3848(07)70134-2.
4
Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.激肽释放酶与蛋白酶介导的信号传导:蛋白酶激活受体(PARs)以及炎症性疾病和癌症的病理生理学
Biol Chem. 2008 Jun;389(6):643-51. doi: 10.1515/BC.2008.077.
5
Protease-activated receptors: contribution to physiology and disease.蛋白酶激活受体:对生理和疾病的作用
Physiol Rev. 2004 Apr;84(2):579-621. doi: 10.1152/physrev.00028.2003.
6
Protease-activated receptors, apoptosis and tumor growth.蛋白酶激活受体、细胞凋亡与肿瘤生长。
Pathophysiol Haemost Thromb. 2008;36(3-4):137-47. doi: 10.1159/000175152. Epub 2009 Jan 27.
7
Protease-activated receptor signaling: new roles and regulatory mechanisms.蛋白酶激活受体信号传导:新作用与调控机制
Curr Opin Hematol. 2007 May;14(3):230-5. doi: 10.1097/MOH.0b013e3280dce568.
8
Structure, function and pathophysiology of protease activated receptors.蛋白酶激活受体的结构、功能和病理生理学。
Pharmacol Ther. 2011 Jun;130(3):248-82. doi: 10.1016/j.pharmthera.2011.01.003. Epub 2011 Jan 26.
9
Thrombin and protease-activated receptors (PARs) in atherothrombosis.凝血酶与蛋白酶激活受体(PARs)在动脉粥样硬化血栓形成中的作用
Thromb Haemost. 2008 Feb;99(2):305-15. doi: 10.1160/TH07-08-0481.
10
Matrix metalloproteinases target protease-activated receptors on the tumor cell surface.基质金属蛋白酶作用于肿瘤细胞表面的蛋白酶激活受体。
Cancer Cell. 2005 Mar;7(3):207-8. doi: 10.1016/j.ccr.2005.02.011.

引用本文的文献

1
Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer.蛋白酶激活受体F2R是卵巢癌患者新的诊断/预后及治疗应用的潜在靶点。
Int J Mol Sci. 2025 Sep 2;26(17):8529. doi: 10.3390/ijms26178529.
2
The protease-activated receptors are expressed in glioblastoma and differentially modulate adherent versus stem-like growth of LN-18 GBM cells.蛋白酶激活受体在胶质母细胞瘤中表达,并对LN - 18胶质母细胞瘤细胞的贴壁生长与干细胞样生长进行差异性调节。
Front Oncol. 2025 Jul 22;15:1582996. doi: 10.3389/fonc.2025.1582996. eCollection 2025.
3
Integrative single-cell and spatial transcriptomics uncover ELK4-mediated mechanisms in + tumor cells driving gastric cancer progression, metabolic reprogramming, and immune evasion.
整合单细胞和空间转录组学揭示ELK4介导的肿瘤细胞驱动胃癌进展、代谢重编程和免疫逃逸的机制。
Front Immunol. 2025 Jul 4;16:1591123. doi: 10.3389/fimmu.2025.1591123. eCollection 2025.
4
Synthesis and Development of a Novel First-in-Class Cofilin Inhibitor for Neuroinflammation in Hemorrhagic Brain Injury.新型原肌球蛋白抑制剂的合成与开发及其在脑出血性脑损伤中的神经炎症作用
ACS Chem Neurosci. 2022 Apr 6;13(7):1014-1029. doi: 10.1021/acschemneuro.2c00010. Epub 2022 Mar 18.
5
Intrinsic Expression of Coagulation Factors and Protease Activated Receptor 1 (PAR1) in Photoreceptors and Inner Retinal Layers.感光细胞和视网膜内层固有凝血因子和蛋白酶激活受体 1(PAR1)的表达。
Int J Mol Sci. 2022 Jan 17;23(2):984. doi: 10.3390/ijms23020984.
6
Multi-Omics Analysis for Transcriptional Regulation of Immune-Related Targets Using Epigenetic Data: A New Research Direction.基于表观遗传学数据的免疫相关靶点转录调控的多组学分析:一个新的研究方向。
Front Immunol. 2022 Jan 3;12:741634. doi: 10.3389/fimmu.2021.741634. eCollection 2021.
7
An Insight into GPCR and G-Proteins as Cancer Drivers.G 蛋白偶联受体(GPCR)和 G 蛋白作为癌症驱动因素的深入了解。
Cells. 2021 Nov 24;10(12):3288. doi: 10.3390/cells10123288.
8
The role of protease-activated receptor 1 signaling in CD8 T cell effector functions.蛋白酶激活受体1信号传导在CD8 T细胞效应功能中的作用。
iScience. 2021 Oct 30;24(11):103387. doi: 10.1016/j.isci.2021.103387. eCollection 2021 Nov 19.
9
MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence.MMP1 通过成纤维细胞衰老驱动大细胞肺癌的肿瘤进展。
Cancer Lett. 2021 Jun 1;507:1-12. doi: 10.1016/j.canlet.2021.01.028. Epub 2021 Mar 6.
10
Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway.Twist 介导的 PAR1 诱导通过抑制 Hippo 通路促进乳腺癌的进展和转移。
Cell Death Dis. 2020 Jul 9;11(7):520. doi: 10.1038/s41419-020-2725-4.